Panagora Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History

Panagora Asset Management’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$724K	Buy	+56,706	New	+$732K	﹤0.01%	807
2021 Q3	–	Hold	0	–	-$6K	–	2341
2021 Q2	–	Hold	0	–	–	–	2449
2018 Q4	–	Hold	0	–	-$4K	–	2519
2018 Q3	–	Hold	0	–	–	–	2354
2015 Q3	–	Hold	0	–	-$33K	–	2422
2015 Q2	–	Hold	0	–	–	–	2224

Other funds holding TNXP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ishara Investments Los Angeles, California $136M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Panagora Asset Management's TNXP Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 56,706 shares worth $724K. The stake represents ﹤0.01% of the portfolio and ranks #807 among its holdings.

103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

Panagora Asset Management held 56,706 shares of Tonix Pharmaceuticals worth $724K as of Q2 2026.
Tonix Pharmaceuticals was a new Panagora Asset Management position in Q2 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #807 holding.
103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.